Clinical trial
Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients - Pilot Study
NCT02417168 is registered in ClinicalTrials.gov with CAMC Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients - Pilot Study
- Lead sponsor
- CAMC Health System
- Phase
- Observational
- Overall status
- Terminated
- Start date
- July 1, 2015
- Completion date
- March 1, 2016
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bacteremia, cancer